80.00
price up icon5.54%   4.20
after-market アフターアワーズ: 79.75 -0.25 -0.31%
loading
前日終値:
$75.80
開ける:
$81.5
24時間の取引高:
15.66M
Relative Volume:
3.55
時価総額:
$46.93B
収益:
$5.69B
当期純損益:
$4.15B
株価収益率:
11.51
EPS:
6.95
ネットキャッシュフロー:
$623.10M
1週間 パフォーマンス:
+4.59%
1か月 パフォーマンス:
+3.94%
6か月 パフォーマンス:
+15.96%
1年 パフォーマンス:
+34.00%
1日の値動き範囲:
Value
$77.52
$83.00
1週間の範囲:
Value
$75.39
$83.00
52週間の値動き範囲:
Value
$59.41
$83.00

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1164)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
15,800
Name
Twitter
@edwardslifesci
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

EW を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
80.00 44.46B 5.69B 4.15B 623.10M 6.95
Medical Devices icon
ABT
Abbott Laboratories
126.54 218.59B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.14 157.13B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
403.53 151.59B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.94 118.29B 33.54B 4.66B 5.19B 3.62

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
10:28 AM

Edwards Lifesciences Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

10:28 AM
pulisher
03:48 AM

Edwards Lifesciences stock price target raised to $84 from $75 at TD Cowen - Investing.com

03:48 AM
pulisher
03:48 AM

Edwards Lifesciences stock price target raised to $89 at RBC on growth outlook - Investing.com

03:48 AM
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Target Price Raised by JP Morgan | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences sales up nearly 12% in Q2 - MassDevice

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corporation Stock Analysis and ForecastPhenomenal returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Q2 EarningsEdwards Lifesciences (NYSE:EW) - Benzinga

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Exec Larry Wood Departs for Procept BioRobotics - Orange County Business Journal

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Target Price Raised by Baird Analyst | - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences’ MITRIS Valve Study: A Key Development for Investors - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results - Benzinga

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Surpasses Earnings and Revenue Expecta - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Q2 2025 Earnings Report - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences stock reaches 52-week high at 81.86 USD - Investing.com

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Receives Price Target Upgrade from Deutsche Bank | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Receives Price Target Boost from Baird | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

JPMorgan Adjusts Edwards Lifesciences (EW) Price Target Following Strong Q2 Results | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards loses longtime TAVR leader Larry Wood - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... By GuruFocus - Investing.com Canada

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised Guidance - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Reports Strong Q2 Growth - TipRanks

Jul 25, 2025
pulisher
Jul 24, 2025

Earnings call transcript: Edwards Lifesciences Q2 2025 beats forecasts, stock dips By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences (EW) Surges After Earnings Report | EW Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO - GlobeNewswire Inc.

Jul 24, 2025
pulisher
Jul 24, 2025

After-hours movers: Edwards Lifesciences, Intel, Deckers Brands and more - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences Corp Reports Q2 Revenue of $1.53 Billion, E - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences shares leap 7% on strong Q2 results, sales growth guidance - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences Corp. Reports Retreat In Q2 Income - Nasdaq

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences earnings beat by $0.05, revenue topped estimates - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences Reports Second Quarter Results - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards recalls certain arterial cannula devices - MassDevice

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences (EW) Awaits Key Earnings Report | EW Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 22, 2025

EDWARDS LIFESCIENCES Earnings Preview: Recent $EW Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

Edwards Lifesciences Corp expected to post earnings of 62 cents a shareEarnings Preview - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Heart Valve Devices Market is projected to grow US$ 34.6 billion - openPR.com

Jul 22, 2025
pulisher
Jul 21, 2025

Curious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance

Jul 21, 2025
pulisher
Jul 19, 2025

Earnings Preview: What To Expect From Edwards Lifesciences' Report - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Lobbying Update: $360,000 of EDWARDS LIFESCIENCES LLC lobbying was just disclosed - Quiver Quantitative

Jul 19, 2025
pulisher
Jul 19, 2025

Edwards Lifesciences to Announce Q2 2025 Results, Driving Growth in Structural Heart Innovations - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

What drives Edwards Lifesciences Corporation stock priceHigh-yield growth strategies - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025 - Yahoo Finance

Jul 18, 2025
pulisher
Jul 15, 2025

Morgan Stanley Adjusts Price Target on Edwards Lifesciences to $81 From $75, Maintains Equalweight Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

Edwards Lifesciences Seeks to Add to its Irvine Campus - Orange County Business Journal

Jul 14, 2025
pulisher
Jul 11, 2025

Edwards Lifesciences’ PROGRESS Trial: A Game-Changer for Aortic Stenosis Treatment? - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Edwards Lifesciences Launches MITRIS Valve Study in China: A Potential Market Game-Changer - TipRanks

Jul 11, 2025
pulisher
Jul 10, 2025

Argus Initiates Edwards Lifesciences at Buy, $90 Price Target - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Edwards Lifesciences’ SAPIEN X4 Valve Study: A Potential Game-Changer in Heart Valve Treatment - TipRanks

Jul 10, 2025

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.61
price up icon 1.09%
$88.99
price up icon 2.59%
medical_devices PHG
$26.16
price up icon 1.24%
medical_devices STE
$230.46
price up icon 1.41%
$290.22
price up icon 1.27%
大文字化:     |  ボリューム (24 時間):